STOCKTON, CALIFORNIA/November 27, 2012 /Newswire/ -- Viratech Corp. (OTC: VIRA), the first open source biotech research social network platform, announced today the membership of I. Christopher Hudlin Jr. M.D. to its Advisory Committee. Dr. Hudlin serves in the General and Thoracic Surgery Department, and is the Chairman in the Department of Surgery of Gould Medical Group, Sutter Health, Central Valley Region.
Dr. Hudlin went to Michigan State University graduating with a degree in biochemistry in 1976. Dr. Hudlin completed medical school at Washington University School of Medicine in St. Louis in 1976. Dr. Hudlin did my general surgery residency in the Air Force at David Grant Medical Center, Travis AFB, California. Dr. Hudlin received an Air Force Achievement Award there. After completion of his residency in 1985, Dr. Hudlin spent 3 years at Vandenberg AFB as a staff surgeon and Chief, Hospital Services for USAF Hospital, Vandenberg AFB. Dr. Hudlin started private practice in Stockton, California in 1988. Dr. Hudlin was CEO of Sierra Multisurgical Associates, a multisurgical group, from 1994-2007.
Dr. Hudlin joined Gould Medical Group in 2007 and became General Surgery Section Chief and Chairman, Department of Surgery in 2009. Dr. Hudlin attended a number of management and leadership training courses since joining Sutter/Gould. He is the Chairman Surgical Trauma/Quality Assurance committee, and General Surgical section chief at St. Joseph's Medical Center, Stockton. He is on the clinical research committee for Sutter Gould.
“I am passionate about medicine and an entrepreneur by nature, and I believe strongly that ongoing research and development, coordination of care, and using medications and alternative treatments to fight diseases are the way of the future in improving outcomes and reducing the cost of healthcare,” states Dr. Hudlin.
About Viratech Corp.
Based in Stockton, California, Viratech Corp. has created an open source biotech research and development platform, Viratech has created a unique platform leveraging the utility of social collaboration, which will allow cancer research the opportunity for the first time to become open sourced. This is accomplished by allowing our development partners the ability to protect, promote and produce their research in unified online collaboration hubs known as micro social networks. Viratech’s open source platform has integrated several intellectual property tools which, by leveraging our social collaboration network, can give our development partners a new intellectual property mechanism, which will help in addressing the protection of Intellectual Property, promotion through collaboration in our protected open source platform, and commercial development of the products achieved through collaborative research.
Using this platform, Viratech members can protect their intellectual property, then use Viratech’s micro social network as a utility to promote and crowdfund the research and development to produce the new technology.
This press release includes forward-looking statements concerning the future performance of our business, its operations and its financial performance and condition, and also includes selected operating results presented without the context of accompanying financial results. These forward-looking statements include, among others, statements with respect to our objectives and strategies to achieve those objectives, as well as statements with respect to our beliefs, plans, expectations, anticipations, estimates or intentions. These forward-looking statements are based on our current expectations. We caution that all forward-looking information is inherently uncertain and actual results may differ materially from the assumptions, estimates or expectations reflected or contained in the forward-looking information, and that actual future performance will be affected by a number of factors, including economic conditions, technological change, regulatory change and competitive factors, many of which are beyond our control. Therefore, future events and results may vary significantly from what we currently foresee. We are under no obligation (and we expressly disclaim any such obligation) to update or alter the forward-looking statements whether as a result of new information, future events or otherwise.
Contact: Dr. Kevin Buckman
Email Contact: email@example.com